The BD MAX™️ Portfolio of Respiratory assays
The efficiency and versatility offered by the BD MAX™ System and the Respiratory portfolio facilitate high volume molecular testing for rapid diagnosis and treatment.
Detection of highly transmissible respiratory pathogens
The efficiency and versatility offered by the BD MAX™ System and the Respiratory portfolio facilitate high volume molecular testing for rapid diagnosis and treatment.
Globally, every year there are an estimated 1 billion cases of seasonal influenza, of which 3 to 5 million are severe cases1
TB remains the world’s top infectious killer with 10 million contracting the disease each year and 1.5 million deaths2
Global pandemics occur when new strains occur of known respiratory viruses.
Diagnosis of acute respiratory infections can be difficult
Rapid and accurate diagnosis is critical
SARS-CoV-2 (N1)
SARS-CoV-2 (N2)
SARS-CoV-2 (N1 + N2)
Influenza A
Influenza B
Mycobacterium tuberculosis complex (MTBC)
Rifampin resistance (RIF)
Isoniazid resistance (INH)
SARS-CoV-2 (N1+N2)
Influenza A
Influenza B
RSV
SARS-CoV-2 (N1)
SARS-CoV-2 (N2)
Influenza A
Influenza B
Human Respiratory Syncytial Viruses (RSV)
B.1.1.7 (Alpha) variant (69/70 deletion)
B.1.351 (Beta) variant (K417N mutation)
P.1 (Gamma) variant (K417T mutation)
B.1.617 (Delta) variant (P681R + L452R mutations)
SARS-CoV-2 (N1)
SARS-CoV-2 (N2)
Influenza A
Influenza B
RSV
Pneumocystis jirovecii
The BD MAX™ System is a single platform
capable of running BD and partner developed assays,
as well as laboratory-developed tests.
INH, isoniazid; MTBC, Mycobacterium tuberculosis complex; PCR, polymerase chain reaction; RIF, rifampicin; RSV, respiratory syncytial virus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TB, tuberculosis
BD, the BD Logo, BD MAX are trademarks of Becton, Dickinson and Company or its affiliates. © 2023 BD. All rights reserved.
The BD MAX™ System, BD MAX™ Enteric Bacterial & Extended Enteric Bacterial Panels, BD MAX™ Enteric Viral Panel & BD MAX™ Enteric Viral Panel-NR, BD MAX™ Enteric Parasite Panel, BD MAX™ Vaginal Panel, BD MAX™ Check-Points CPO, BD MAX™ MRSA XT & BD MAX™ StaphSR, BD MAX™ Cdiff, BD MAX™ MDR-TB, BD SARS-CoV-2 Reagents for BD MAX™ System, BD SARS-CoV-2/Flu for BD MAX™ System, VIASURE SARS-CoV-2 (N1+N2) Real Time PCR Detection Kit for BD MAX™ System, VIASURE SARS-CoV-2, Flu (A+B) & RSV Real Time PCR Detection Kit for BD MAX™ System, VIASURE Flu A, Flu B & RSV Real Time PCR Detection Kit for BD MAX™ System, VIASURE Vancomycin Resistance Real Time PCR Detection Kit for BD MAX™ System are in vitro diagnostic medical devices bearing a CE mark.
The BD CTGC2 and BD CTGCTV2 for BD MAX™ System assays are in vitro diagnostic medical devices bearing a CE mark and are CE certified by BSI Group The Netherlands B.V. (Notified Body Number = 2797).